Annual Total Assets
$1.55 B
-$20.87 M-1.33%
December 31, 2024
Summary
- As of March 10, 2025, PCRX annual total assets is $1.55 billion, with the most recent change of -$20.87 million (-1.33%) on December 31, 2024.
- During the last 3 years, PCRX annual total assets has fallen by -$521.84 million (-25.14%).
- PCRX annual total assets is now -25.14% below its all-time high of $2.08 billion, reached on December 31, 2021.
Performance
PCRX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$1.55 B
+$31.82 M+2.09%
December 31, 2024
Summary
- As of March 10, 2025, PCRX quarterly total assets is $1.55 billion, with the most recent change of +$31.82 million (+2.09%) on December 31, 2024.
- Over the past year, PCRX quarterly total assets has stayed the same.
- PCRX quarterly total assets is now -25.14% below its all-time high of $2.08 billion, reached on December 31, 2021.
Performance
PCRX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
PCRX Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.3% | 0.0% |
| 3 y3 years | -25.1% | 0.0% |
| 5 y5 years | +86.9% | 0.0% |
PCRX Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | at low | -25.1% | +2.1% |
| 5 y | 5-year | -25.1% | +86.9% | -25.1% | +89.1% |
| alltime | all time | -25.1% | +3434.4% | -25.1% | +3434.4% |
Pacira BioSciences Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.55 B(-1.3%) | $1.55 B(+2.1%) |
| Sep 2024 | - | $1.52 B(-7.6%) |
| Jun 2024 | - | $1.65 B(+4.0%) |
| Mar 2024 | - | $1.58 B(+0.6%) |
| Dec 2023 | $1.57 B(-6.4%) | $1.57 B(+2.6%) |
| Sep 2023 | - | $1.53 B(-0.5%) |
| Jun 2023 | - | $1.54 B(+1.2%) |
| Mar 2023 | - | $1.52 B(-9.4%) |
| Dec 2022 | $1.68 B(-19.0%) | $1.68 B(-3.1%) |
| Sep 2022 | - | $1.73 B(+0.0%) |
| Jun 2022 | - | $1.73 B(-8.3%) |
| Mar 2022 | - | $1.89 B(-8.9%) |
| Dec 2021 | $2.08 B(+62.8%) | $2.08 B(+53.0%) |
| Sep 2021 | - | $1.36 B(+2.3%) |
| Jun 2021 | - | $1.33 B(+3.0%) |
| Mar 2021 | - | $1.29 B(+1.0%) |
| Dec 2020 | $1.27 B(+53.4%) | $1.27 B(+4.4%) |
| Sep 2020 | - | $1.22 B(+40.9%) |
| Jun 2020 | - | $866.11 M(+5.4%) |
| Mar 2020 | - | $821.38 M(-1.2%) |
| Dec 2019 | $831.07 M(+20.6%) | $831.07 M(+2.9%) |
| Sep 2019 | - | $807.49 M(+2.5%) |
| Jun 2019 | - | $787.84 M(+9.6%) |
| Mar 2019 | - | $719.16 M(+4.3%) |
| Dec 2018 | $689.35 M(+9.7%) | $689.35 M(+4.6%) |
| Sep 2018 | - | $659.04 M(+2.5%) |
| Jun 2018 | - | $642.68 M(+3.3%) |
| Mar 2018 | - | $622.04 M(-1.0%) |
| Dec 2017 | $628.37 M | $628.37 M(+3.7%) |
| Sep 2017 | - | $606.09 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $605.75 M(+1.0%) |
| Mar 2017 | - | $599.96 M(+53.3%) |
| Dec 2016 | $391.47 M(+1.0%) | $391.47 M(+2.7%) |
| Sep 2016 | - | $381.15 M(-4.9%) |
| Jun 2016 | - | $400.70 M(+2.4%) |
| Mar 2016 | - | $391.21 M(+0.9%) |
| Dec 2015 | $387.74 M(+18.9%) | $387.74 M(+5.1%) |
| Sep 2015 | - | $368.99 M(+3.9%) |
| Jun 2015 | - | $354.99 M(+6.0%) |
| Mar 2015 | - | $335.03 M(+2.7%) |
| Dec 2014 | $326.07 M(+92.0%) | $326.07 M(+6.8%) |
| Sep 2014 | - | $305.39 M(+4.6%) |
| Jun 2014 | - | $292.08 M(+78.4%) |
| Mar 2014 | - | $163.69 M(-3.6%) |
| Dec 2013 | $169.82 M(+51.6%) | $169.82 M(-1.5%) |
| Sep 2013 | - | $172.40 M(-3.4%) |
| Jun 2013 | - | $178.43 M(-3.7%) |
| Mar 2013 | - | $185.24 M(+65.3%) |
| Dec 2012 | $112.05 M(-1.3%) | $112.05 M(-15.6%) |
| Sep 2012 | - | $132.83 M(-7.0%) |
| Jun 2012 | - | $142.85 M(+51.5%) |
| Mar 2012 | - | $94.26 M(-16.9%) |
| Dec 2011 | $113.49 M(+70.5%) | $113.49 M(+46.2%) |
| Sep 2011 | - | $77.61 M(-10.9%) |
| Jun 2011 | - | $87.09 M(-11.0%) |
| Mar 2011 | - | $97.87 M(+47.0%) |
| Dec 2010 | $66.56 M(+51.4%) | $66.56 M(+26.2%) |
| Sep 2010 | - | $52.76 M(+5.0%) |
| Jun 2010 | - | $50.24 M(+14.3%) |
| Dec 2009 | $43.95 M(-13.0%) | $43.95 M |
| Dec 2008 | $50.54 M | - |
FAQ
- What is Pacira BioSciences annual total assets?
- What is the all time high annual total assets for Pacira BioSciences?
- What is Pacira BioSciences annual total assets year-on-year change?
- What is Pacira BioSciences quarterly total assets?
- What is the all time high quarterly total assets for Pacira BioSciences?
- What is Pacira BioSciences quarterly total assets year-on-year change?
What is Pacira BioSciences annual total assets?
The current annual total assets of PCRX is $1.55 B
What is the all time high annual total assets for Pacira BioSciences?
Pacira BioSciences all-time high annual total assets is $2.08 B
What is Pacira BioSciences annual total assets year-on-year change?
Over the past year, PCRX annual total assets has changed by -$20.87 M (-1.33%)
What is Pacira BioSciences quarterly total assets?
The current quarterly total assets of PCRX is $1.55 B
What is the all time high quarterly total assets for Pacira BioSciences?
Pacira BioSciences all-time high quarterly total assets is $2.08 B
What is Pacira BioSciences quarterly total assets year-on-year change?
Over the past year, PCRX quarterly total assets has changed by $0.00 (0.00%)